skip to content
   


MARKET POTENTIAL PROJECTIONS

  • Market potential based on demographics-not current market estimated by industry
  • Derived from THE SAGE GROUP estimates of disease prevalence
  • Based on estimates of prevalence, percentage diagnosed, percentage treated and numbers of people that could potentially be treated with a therapy
  • Provided for both pharmaceutical and interventional technologies
  • Forecast by therapeutic category from 2000 through 2020
  • Forecast by vascular territory from 2000 through 2020

 

Primary Sources are Peer-Reviewed Medical Research


RECENTLY PUBLISHED:

Chronic Venous Disease (CVD) Epidemiology, Costs and Consequences

Additional Information

 

Powered by Website Baker, design by Atlanta Based MaxxWebs Design and Development